# Recipharm Monts, Monts, France – FDA Inspections

Source: https://www.keypedia.com/companies/recipharm-monts/e3b2f0c3-26eb-4020-8127-76127e9e18d6

> Inspection records and compliance data for Recipharm Monts in Monts. 4 FDA inspections on record (1 OAI), last inspected October 18, 2022.

---

## Details

- Name: Recipharm Monts
- FEI Number: 1000171152
- Facility Type: Pharmaceutical Manufacturer
- Address Line 1: Site de Monts Sud, 18 rue de Montbazon
- City: Monts
- Country Name: France
- Address: Site de Monts Sud, 18 rue de Montbazon, Monts, France
- Country: France

## Related Documents

- [483 - Recipharm Monts - 2022-10-18](https://www.keypedia.com/records/483/recipharm-monts/a83c3605-dbd3-4083-aab4-aa70216b587a) — source: FDA, date: October 18, 2022
- [FDA Inspection 1181620 - Recipharm Monts - 2022-10-18](https://www.keypedia.com/records/fda_inspections/recipharm-monts/1e8094d2-a501-42d5-a694-2a4acf3c64b3) — classification: Official Action Indicated (OAI), source: FDA, date: October 18, 2022
- [483 - Recipharm Monts - 2019-11-12](https://www.keypedia.com/records/483/recipharm-monts/8da3ebc9-c75d-42d0-9fd6-150cb677753c) — source: FDA, date: November 12, 2019
- [FDA Inspection 1116762 - Recipharm Monts - 2019-03-29](https://www.keypedia.com/records/fda_inspections/recipharm-monts/6d6f7f96-cd3d-4333-9ca1-8e5e161ed82d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2019
- [FDA Inspection 940945 - Recipharm Monts - 2015-06-09](https://www.keypedia.com/records/fda_inspections/recipharm-monts/b0930f8a-db4b-4f30-83a8-668fdf63cee8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 9, 2015
- [483 - Recipharm Monts - 2013-02-26](https://www.keypedia.com/records/483/recipharm-monts/01138d7a-dab5-495d-a5da-6e0f03eb5d1e) — source: FDA, date: February 26, 2013
- FDA Inspection 821445 - Recipharm Monts - 2013-02-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2013

## Related Companies

- [Oxford Pharmaceuticals, LLC](https://www.keypedia.com/companies/oxford-pharmaceuticals-llc/5294310a-05a2-4599-bf9e-720929f040ee)
- [Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)](https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-high-tech-zone-site/94263442-b5c4-4df8-b563-30ae0b9a4206)
- [InvaTech Pharma Solutions, LLC](https://www.keypedia.com/companies/invatech-pharma-solutions-llc/a4957f07-dcf0-47ec-a41a-7effe7e4a8e3)
- [Maiva Pharma Private Limited](https://www.keypedia.com/companies/maiva-pharma-private-limited/3231d685-f5ad-401e-b1ae-66c6a6d8e8b7)
- [Indoco Remedies Limited (Plant I)](https://www.keypedia.com/companies/indoco-remedies-limited-plant-i/cdf789a3-1db2-4bf5-92b5-d6771ea5df48)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Modavar Pharmaceuticals](https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [Procter & Gamble Manufactura S. de R.L. de C.V.](https://www.keypedia.com/companies/procter-gamble-manufactura-s-de-rl-de-cv/8b78eeab-6efe-4a8d-b98a-c1bfda966646)
- [Novitium Pharma LLC](https://www.keypedia.com/companies/novitium-pharma-llc/056d60b0-f42a-4b34-987f-749ffff0520a)

## Related Officers

- [S. Lori. Brown](https://www.keypedia.com/people/s-lori-brown/4bc9d367-3842-404d-a787-b8ce01e20da4)
- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)
- [Drug National Expert](https://www.keypedia.com/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)
